VasoVASO +5.27%43 FCF Margin % is -67.60% as of Mar. 2026. GuruFocus rates VASO with a GF Score™ of 43/100 and a GF Value™ of $0.18 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Vaso ranks worse than 68.01% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vaso's Free Cash Flow for the
three
months ended in Mar. 2026 was $-13.08 Mil. Vaso's Revenue for the
three
months ended in Mar. 2026 was $19.36 Mil. Therefore, Vaso's FCF Margin % for the quarter that ended in Mar. 2026 was -67.60%.
The historical rank and industry rank for Vaso's FCF Margin % or its related term are showing as below:
VASO'
s FCF Margin % Range Over the Past 10 Years
Min: -5.46 Med: 5.12 Max: 17.47
Current: -4.28
During the past 13 years, the highest FCF Margin % of Vaso was 17.47%. The lowest was -5.46%. And the median was 5.12%.
VASO's FCF Margin % is ranked worse than 68.01% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.34
vs VASO: -4.28
Vaso FCF Margin % Related Terms
Vaso FCF Margin % Historical Data
* Premium members only.
The historical data trend for Vaso's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Vaso's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaso FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vaso's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Vaso's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaso (VASO) has a FCF Margin % of -67.60% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vaso and its competitors. According to the industry distribution chart, Vaso ranks #455 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 68%.
Is Vaso's FCF Margin % too high?
Vaso's current FCF Margin % is -67.60%. Based on the distribution chart, Vaso ranks #455 out of 669 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Vaso has a GF Score™ of 43/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vaso's FCF Margin % compare to ONMD and CRVW?
According to the Healthcare Providers & Services industry distribution chart, Vaso ranks #455 out of 669 companies for FCF Margin %. This places Vaso in the lower half of its industry. The industry median FCF Margin % is 3.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.34, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vaso and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaso's current FCF Margin % is -67.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaso stock overvalued right now?
Based on GuruFocus' analysis, Vaso (VASO) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.18, compared to a current price of $0.20 — trading 11.1% above its estimated fair value. The current FCF Margin % is -67.60%. Vaso's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vaso (VASO), the current FCF Margin % is -67.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vaso (VASO) Overvalued in 2026?
Based on GuruFocus' analysis, Vaso stock appears to be overvalued.
The current stock price of $0.20 is trading 11.1% above its estimated GF Value™ of $0.18.
GuruFocus considers Vaso to be Modestly Overvalued.
Key valuation signals for VASO:
FCF Margin %: -67.60%
GF Value™: $0.18 vs. price of $0.20 (11.1% above fair value)
No single metric tells the full story. See the VASO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vaso Corp is a medical technology company. It provides diverse product and service categories, including noninvasive monitoring and therapeutic devices, diagnostic imaging equipment, and information technology for enterprises and clinical customers. The company currently operates in three distinct business units namely IT; Professional sales and Equipment. IT segment focuses on healthcare IT and managed network technology services.
43GF Score
Get the complete analysis for VASO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VASO has been successfully added to your 
